Evidence map›Paper›PMID 39921694›Full record

ArticleInternational immunology2025

Correlation of interferons and autoimmune aspects in long COVID-19 patients.

Fumiyuki Hattori, Junji Nishiyama, Hideaki Hasuo

Erratum issuedAbstract read
In one paragraph

Article in International immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Fumiyuki HattoriInnovative Regenerative Medicine, Graduate School of Medicine, Kansai Medical University, Shinmachi 2-5-1, Hirakata, Osaka 573-1010, Japan.ORCID 0000-0002-8936-9941
Junji NishiyamaDepartment of Psychosomatic Medicine, Kansai Medical University, Shinmachi 2-5-1, Hirakata, Osaka 573-1090, Japan.
Hideaki HasuoDepartment of Psychosomatic Medicine, Kansai Medical University, Shinmachi 2-5-1, Hirakata, Osaka 573-1090, Japan.ORCID 0000-0001-8094-9029

Funding

Kawano Masanori Memorial Public Interest Incorporated Foundation COVID-19- K027083
6 · The paper itself

Abstract

Long COVID, or post-acute sequelae of COVID-19 (PASC), represents a major global health challenge, with its underlying mechanisms remaining poorly understood despite substantial research and clinical trials. This study investigates the role of the interferon (IFN) axis in the pathogenesis of PASC, drawing parallels to systemic lupus erythematosus (SLE). The potential pathogenic role of IFNs was detected by meta-analyses of mRNA sequencing data comparing PASC patients to healthy controls. We analyzed serum samples from 39 PASC patients and found significant correlations among multiple IFN sub types, including IFN alpha-2, beta, gamma, lambda-1, and lambda-2/3. The biological activity of IFNs in the serum was positively correlated with levels of both total and type III IFNs. Notably, we detected the widespread presence of anti-double-stranded DNA (anti-dsDNA) and anti-Smith (anti-Sm) antibodies in these patients, with anti-dsDNA levels showing a strong correlation with IFN activity. On the basis of these findings, we propose a hypothetical autoimmune pathogenesis for PASC highlighting the crucial role of IFN signaling.

Indexed as

AutoimmunityCOVID-19InterferonsSARS-CoV-2AdultAgedAntibodies, AntinuclearAutoantibodiesFemaleHumansLupus Erythematosus, SystemicMaleMiddle AgedPost-Acute COVID-19 SyndromeAntibodies, AntinuclearAutoantibodiesInterferonsautoimmune diseasePASCSLE

Identifiers

PMID39921694
PMCPMC12096164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.